Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Apple
AAPL
|
+$2.4B |
| 2 |
Tesla
TSLA
|
+$1.65B |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$606M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$487M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$481M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$708M |
| 2 |
Meta Platforms (Facebook)
META
|
+$678M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$671M |
| 4 |
iShares Floating Rate Bond ETF
FLOT
|
+$655M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
+$498M |
Sector Composition
| 1 | Technology | 16% |
| 2 | Consumer Discretionary | 12.51% |
| 3 | Financials | 6.03% |
| 4 | Healthcare | 4.65% |
| 5 | Communication Services | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$1.88B
| $1.5M | ﹤0.01% |
25,013
+857
| +4% | +$51.5K |
|
2652
Columbia Banking Systems
COLB
$7.73B
| $1.5M | ﹤0.01% |
74,112
-15,201
| -17% | -$308K |
|
2653
NatWest
NWG
$59.2B
| $1.5M | ﹤0.01% |
245,375
+109,674
| +81% | +$671K |
|
2654
iShares Global Utilities ETF
JXI
$217M
| $1.5M | ﹤0.01% |
25,111
-8,990
| -26% | -$537K |
|
2655
CareDx
CDNA
$746M
| $1.5M | ﹤0.01% |
176,531
+47,472
| +37% | +$404K |
|
2656
BellRing Brands
BRBR
$4.47B
| $1.49M | ﹤0.01% |
40,832
+16,785
| +70% | +$614K |
|
2657
Fidelity Stocks for Inflation ETF
FCPI
$242M
| $1.49M | ﹤0.01% |
+45,429
| New | +$1.49M |
|
|
NARI
2658
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.49M | ﹤0.01% |
25,614
-9,531
| -27% | -$554K |
|
2659
Brinker International
EAT
$6.8B
| $1.49M | ﹤0.01% |
40,673
+29,461
| +263% | +$1.08M |
|
2660
Rockwell Medical
RMTI
$57.2M
| $1.49M | ﹤0.01% |
+272,310
| New | +$1.49M |
|
2661
ProShares Ultra Energy
DIG
$70.9M
| $1.49M | ﹤0.01% |
42,016
+28,759
| +217% | +$1.02M |
|
2662
Petrobras Class A
PBR.A
$76.4B
| $1.49M | ﹤0.01% |
+120,166
| New | +$1.49M |
|
2663
A-Mark Precious Metals
AMRK
$667M
| $1.48M | ﹤0.01% |
+39,668
| New | +$1.48M |
|
2664
Angel Oak UltraShort Income ETF
UYLD
$1.11B
| $1.48M | ﹤0.01% |
29,432
+9,432
| +47% | +$476K |
|
|
SBOW
2665
DELISTED
SilverBow Resources, Inc.
SBOW
| $1.48M | ﹤0.01% |
50,776
-8,049
| -14% | -$234K |
|
2666
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.76B
| $1.48M | ﹤0.01% |
+27,964
| New | +$1.48M |
|
2667
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.24B
| $1.48M | ﹤0.01% |
28,227
-107,868
| -79% | -$5.65M |
|
2668
PIMCO Multi Sector Bond Active ETF
PYLD
$7.42B
| $1.47M | ﹤0.01% |
+58,703
| New | +$1.47M |
|
2669
EPAM Systems
EPAM
$8.61B
| $1.47M | ﹤0.01% |
6,545
-3,966
| -38% | -$891K |
|
2670
Carlyle Group
CG
$24.2B
| $1.47M | ﹤0.01% |
46,012
-5,862
| -11% | -$187K |
|
2671
Leonardo DRS
DRS
$11.2B
| $1.47M | ﹤0.01% |
84,693
-114,597
| -58% | -$1.99M |
|
2672
Hercules Capital
HTGC
$3.48B
| $1.47M | ﹤0.01% |
+99,189
| New | +$1.47M |
|
2673
Ardelyx
ARDX
$1.57B
| $1.47M | ﹤0.01% |
433,020
+95,921
| +28% | +$325K |
|
2674
Teradata
TDC
$2.03B
| $1.47M | ﹤0.01% |
27,444
+10,843
| +65% | +$579K |
|
2675
Arcturus Therapeutics
ARCT
$492M
| $1.46M | ﹤0.01% |
51,020
+1,702
| +3% | +$48.8K |
|